Los Angeles-Considering the limited availability of published randomized trials, glaucoma surgeons should remain skeptical about the safety and efficacy of viscocanalostomy and deep sclerectomy with collagen wick, said Donald S. Minckler, MD.
Osheru receives funding to advance Ziplyft device for blepharoplasty surgery
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
Clinical trial recruitment and AI: Easing the burden of GA studies
Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention
FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO
Surgical taming of neurotrophic keratopathy